Multiple Myeloma (Exam 3) Flashcards
MGUS
M protein present, chance of progressing to mutiple myeloma. M protein below 3g/dL and less than 10% plasma cells in bonemarrow.
Mutiple Myeloma
Cancer of plasma cells, my protein present in serum and urine. 4:100k more in african american males. Average age 65. Predominately IgG followed by IgA.
Smoldering Multiple Myeloma
M protein above 3 g/dL and or more than 10% plasma cells in bonemarrow. No end organ damage.
High risk translocation
17p deletion 14;16 and 14;20
Intermediate risk translocation
4;14 and 13 deletion or hypodiploidy by conventional karyotyping
Standard risk
Trisomies, 11;14 and 6;14
Mutiple myeloma treatment
Chemo, steroids, immunomodulators, bone marrow transplant (auto), and bisphosphonates/radiation.
Stem cell transplant in MM
Prolongs survival by 13 months on average, auto only
Plasmacytoma
Isolated mass of plasma cells, can have low levels of M protein. Might have light chain elevation. When its in the bone its harder to treat. Tx: radiation in bone, resection outside.
Amyloidosis
Protein conformation disorder associated with plasma cell dyscrasia. Proteins deposit in the organs. 10% of patients with Myeloma have concurrent amyloidosis.
Amyloidosis Diagonosis
Congo red Staine with red green under polarized light.
Amyloidosis Prognosis
Cardiac involvement is a median survival of 6 mo.
Amyloidosis treatment
CyBorD, restrict further deposition
Waldenstroms macroglobulinemia
Excess igM and lymphplasmacytic lymphoma in marrow. Only treat if symptomatic, chemo. Incurable.